retatrutide triple agonist glp-1 gip glucagon phase 3 2025 Today, we shared new data from two trials of retatrutide, our investigational agonist. Learn more at our link in bio Targeting GLP-1, GIP & GCG

Lipo 360 in Atlanta yields transformative results for patients who wish to achieve a slimmer, firmer looking midsection

Supporting your body with high-quality, bioavailable supplements is a powerful tool, but it works best when paired with adequate sleep, hydration, and a diet rich in whole foods

Images were obtained using a panoramic tissue scanner (Nano Zoomer S60, Hamamatsu, Shizuoka, Japan) and were analyzed using NDP.view software (Hamamatsu)

For twice-daily administration, administer in the AM and at bedtime

Statistical comparisons were made using unpaired t test between groups

Medicinal Chemistry 32, 68826899